NCAPG2 and hepatocellular carcinoma: A deeper dive into TCGA's prognostic data and subsequent Kaplan–Meier survival curve plotting revealed that elevated NCAPG2 expression corresponded to poorer Overall Survival and Progress‐Free Interval outcomes, indicating its association with adverse prognosis in HCC patients (Figure 6D,E).